Intestinal colonization by antibiotic-resistant Enterococcus faecium is the first step in a process that can lead to infections in hospitalized patients. By comparative genome analysis and subsequent polymerase chain reaction screening, we identified a locus that encodes a putative phosphotransferase system (PTS). The PTS locus was widespread in isolates from hospital outbreaks of infection (84.2%) and nonoutbreak clinical infections (66.0%) but absent from human commensal isolates. Deletion of pstD, which is predicted to encode the enzyme IID subunit of this PTS, significantly impaired the ability of E. faecium to colonize the murine intestinal tract during antibiotic treatment. This is the first description of a determinant that contributes to intestinal colonization in clinical E. faecium strains.
Enterococcus faecium is a gram-positive bacterium that inhabits the intestinal tracts of humans and animals as a commensal organism. In the last 2 decades, E. faecium has emerged as a multidrug-resistant nosocomial pathogen causing bacteremia, endocarditis, and surgical wound, urinary tract, and device-related infections in debilitated patients [1] . E. faecium is intrinsically resistant to several clinically important antibiotics and has recently acquired resistance to many more antibiotics, including vancomycin, daptomycin, and linezolid [1] . The establishment of high-level intestinal colonization by enterococci is a crucial step in a process that can lead to nosocomial infections [1] . Once E. faecium has dominantly colonized the gastrointestinal tract, it may cross the intestinal lining and access the bloodstream, causing bacteremia. It can also serve as reservoir for fecal contamination of the urinary tract and skin, ultimately leading to catheter-related infections [1] . 16S ribosomal RNA-based studies have shown that enterococci are present at relatively low levels in the colon and feces of healthy humans. In hospitalized patients, however, enterococci can become one of the most prominent bacterial groups in the gut microbiota, presumably as a consequence of antibiotic therapy [2] . Antibiotic treatment alters intestinal microbial diversity by eliminating susceptible organisms, which provides an opportunity for multidrug-resistant enterococci to colonize these niches [3, 4] . Antibiotic therapy also indirectly enables colonization by multidrug-resistant enterococci, because antibiotic-mediated depletion of the microbiota affects the host intestinal immune defenses [1, 5] .
However, neither the antibiotic resistance of enterococci nor the reduced immune status of the host can explain the notable feature that E. faecium isolates that are responsible for the majority of nosocomial infections are genetically distinct from isolates that are indigenous to humans and animals [6] [7] [8] . This observation implies that nosocomial E. faecium strains possess unique traits that enable them to benefit from the antibiotic-induced perturbations of the intestinal tract in hospitalized patients, thereby facilitating high-level intestinal colonization preceding infection. The specific genetic determinants of nosocomial E. faecium that promote gastrointestinal colonization during antibiotic therapy remain to be identified.
In this study, we describe a comparative genomic analysis that led to the identification of a gene cluster encoding a carbohydrate phosphotransferase system (PTS; here termed "PTS clin ") that is highly enriched in clinical E. faecium isolates but absent from commensal isolates. Deletion of the pstD gene, which is predicted to encode the enzyme IID subunit of PTS clin , significantly impaired the ability of E. faecium to colonize the murine intestinal tract during antibiotic treatment.
METHODS

Bacterial Strains and Growth Conditions
E. faecium isolates (Supplementary Table 1) were routinely grown at 37°C on trypticase soy agar II plates supplemented with 5% sheep blood (Becton Dickinson, Alphen aan den Rijn, the Netherlands) or in brain-heart infusion (BHI) broth.
Comparative Genomics Analysis
Genome sequence information of all publically available E. faecium strains (1 complete and 29 draft genomes) was retrieved from GenBank (available at: ftp://ftp.ncbi.nih.gov/ genomes/Bacteria and ftp://ftp.ncbi.nih.gov/genomes/Bacteria_ DRAFT; accessed May 2012). To determine groups of orthologous proteins in E. faecium, we extracted all 86 257 annotated protein sequences from the 30 E. faecium genomes and used these as input for an all-versus-all sequence similarity search, using BLAST v2.2.24 [9] (default settings were used, except for: -F 'm S', -e 1e-100, and -z 86 257 [ie, the number of sequences in the database]). Groups of orthologous proteins were predicted from the BLAST output, using OrthoMCL v2.0.2 [10, 11] . The E. faecium core proteome was defined by those orthologous groups that contained exactly 30 proteins, including exactly 1 protein from each of the 30 E. faecium genomes. The core proteome was used to assess E. faecium phylogeny. Associated DNA sequences were extracted for each core protein, after which nucleotide alignments were built per orthologous group, using MUSCLE v3.7 [12] . Prior to concatenating the individual alignments, alignment gaps were removed with TrimAl v1.2 [13] . The alignment contains 1 082 099 bp, including 75 012 variable SNP positions. A bootstrapped neighbor-joining tree was constructed from the concatenated alignment of the SNPs only, using CLUSTAL W v2.0.10 [14] and running 1000 bootstraps ( Figure 1A) . Proteins that were exclusively present in ≥80% isolates of clade A were identified. TX0133B, TX0133C, TX0133a01, and TX0133a04 were excluded in this analysis because they represent the same strain as TX0133A [15] .
Multiple genome alignment was performed using the comparative genomics tool VistaPoint [16] Table 1) were screened for the presence of the PTS clin gene cluster. The presence of this gene cluster was determined by multiplex PCR, in which a pair of primers specific for the E. faecium housekeeping gene ddl (5′-AAAAAGAAATCGCACCG-3′ and 5′-GA GACATTGAATATGCCTTATG-3′) and a pair of primers specific for ptsD (5′-TATCAACGCGATCAAAACGA-3′ and 5′-CGTTCGCATACAGCTTTTCA-3′) were mixed together for each PCR reaction. The PCR products of ddl and ptsD were 560 bp and 242 bp, respectively. The conditions for PCR amplification, performed using HotStarTaq and a volume of 25 µL, were as follows: initial denaturation was conducted for 15 minutes at 95°C, and 30 cycles of denaturation, annealing, and extension were conducted at 94°C for 30 seconds, 55°C for 30 seconds, and 72°C for 30 seconds, respectively, with the time depending on the size of the PCR product. All tested strains were positive for ddl. Analysis of multilocus sequence typing (MLST) data was performed using the goeBURST algorithm [17] .
Construction of ptsD Deletion Mutant
The construction of a double-crossover mutant in the ptsD gene (NCBI accession number ZP_06677678) was performed as described previously [18] . E. faecium E1162 was used as the parental strain for the mutant construction. E1162 was isolated from a patient with hospital-acquired bloodstream infection, and its genome sequence has previously been determined [19] . The MLST type of E1162 is 17, which is a common sequence type in clinical isolates [8] . Briefly, the 5′ flanking regions of ptsD was PCR amplified using primers 5′-CCGCTCGAGCG CAGTTGGAACGATTATTG-3′ and 5′-CCAAAAGAATT CAAGGAATGGTCGTCGAAAAAT-3′, and the 3′ flanking region was PCR amplified using primers 5′-CGACGAC CATTCCTTGAATTCTTTTGGAATGGTCGTCTTGG-3′ and 5′-CCCCCCGGGCGATGATCCGATTCTGACAA-3′. The 2 flanking regions were then fused together by fusion PCR (generating an EcoRI site between both fragments) and cloned into pWS3 [20] , resulting in pDEL5a. Then, a gentamicin-resistance cassette that was flanked by lox66 and lox71 sites [18] was cloned into the EcoRI site that was generated between the 5′ and 3′ flanking regions in pDEL5a, resulting plasmid pDEL5b, which was then electrotransformed into E. faecium E1162. The ptsD mutant, in which the ptsD gene was replaced by a gentamicin-resistance cassette, was obtained by growing the gentamicin-resistant transformants at appropriate temperatures with appropriate antibiotic supplements, as described previously [18] . The mutant was verified by PCR, using primers 5′-GCCGTTGTTATGGCGTATCT-3′ and 5′-GCGATCGTGTCC TTATTTCC-3′.
Mice Intestinal Colonization
Intestinal colonization of mice by E. faecium strains was performed as described elsewhere [21] [22] [23] , with some modifications. Specific-pathogen-free 7-week-old male BALB/c mice (n = 8; Harlan Sprague-Dawley, Horst, the Netherlands) were decolonized for 2 days with subcutaneous injections of ceftriaxone (12 mg/mL; 100 μL per injection) 2 times per day, before inoculation of bacteria. Two days after the initiation of the antibiotic treatment, no E. faecium was identified from the fecal pellets. Mice were then inoculated orogastrically, using a feeding tube with 1 × 10 7 colony-forming units (CFUs) in 300 μL phosphate-buffered saline (PBS) that contained an equal proportion of wild-type E1162 and the ptsD mutant, which were individually grown overnight in BHI broth. Dilutions of the inoculum were plated on Slanetz Bartley agar (SBA; both wild-type E1162 and the mutant strain will grow on these plates) or SBA supplemented with 100 μg/mL gentamicin, to quantify viable counts for the mutant. After inoculation, the mice were allowed to drink ad libitum from water supplemented with 0.2 g/L cefoxitin. Stool samples were collected at 1, 3, 6, and 10 days of colonization and used to determine viable counts of wild-type and mutant E. faecium, as described below. Mice were euthanized after 10 days of colonization. The small intestines, cecum, and colon were collected, weighed, and homogenized in 10 volumes of PBS. Viable counts were determined by serially diluting the homogenates and plating the diluted specimens onto SBA or SBA supplemented with 100 μg/mL gentamicin. After incubation at 37°C for 2 days, colonies were counted, and the strain identity was confirmed by PCR detection of the esp gene in E1162 wild-type and mutant strains. The PCR amplification conditions were identical to those described above. The competitive index (CI) of mutant versus wild type was determined as previously described [24] by the following formula: CI = [CFU mutant output/ CFU wild-type output]/[CFU mutant inoculum/CFU wild-type inoculum]. The statistical significance of differences in logtransformed data between wild-type and mutant strains was assessed by the paired 2-tailed Student t test. A P value of < .05 was considered statistically significant. The Animal Care and Use Committee of the University of Amsterdam (Amsterdam, the Netherlands) approved all experiments.
RESULTS
Comparative Genomic Analysis Identified Genes Specifically Present in Clinical E. faecium Isolates
To determine whether specific traits distinguish commensal and clinical E. faecium isolates, we performed genome-wide comparisons with publically available E. faecium genome sequences. Two clearly separated clades were identified, similar to previous analyses ( Figure 1A ) [7, 25] . Most of the clinical isolates are members of clade A, while most of the human commensal isolates belong to clade B ( Figure 1A ). Comparative genomic analysis identified 93 genes (including 9 gene clusters) that were exclusively present in ≥80% isolates of clade A (4 of the 5 TX0133-derived strains were excluded in this analysis; Supplementary Table 2 ). Since gene clusters are more likely than single genes to confer complete functions, further analysis was performed on the gene clusters. We found that the largest gene cluster (cluster 7; Supplementary Table 2 ) was also present in a human commensal strain E1039 that clustered inside clade A, while the second largest gene cluster (cluster 5) was absent in all the commensal strains. We therefore decided to focus on the latter gene cluster, which is 15 kb in size (Figure 2 ) and specifically enriched in clinical isolates. It contains 4 genes that collectively encode a mannose family PTS, which is involved in the active transport of carbohydrates over the cytoplasmic membrane [26] . This gene cluster is chromosomally located in the complete genome sequence of E. faecium Aus0004, and the highly similar gene synteny of the genes flanking this cluster in other E. faecium genomes strongly suggests a chromosomal location in the other genomes, as well. cluster was also identified in 3 of the 17 strains isolated from animals (from swine, poultry, and canines), suggesting a shared reservoir of genetic information for animal and clinical E. faecium strains. Analysis of MLST data of the 160 E. faecium isolates showed that 60 isolates belong to sequence types that are commonly associated with hospital infections [8] . Among these 60 strains, 56 (93%) isolates carried PTS clin , which was significantly more frequent than among the other 100 strains (P < .0001), of which 5 isolates (5%) contained PTS clin ( Figure 1B) . A mannose family PTS is composed of general cytoplasmic enzymes (EI and HPr), carbohydrate-specific cytoplasmic proteins (EIIA and EIIB), and carbohydrate-specific proteins (EIIC and EIID), which, together, form a membrane-associated complex [26] . In this study, we constructed a deletion mutant of the ptsD gene, which encodes a sugar-specific membraneassociated EIID subunit that is required for carbohydrate transport [26] . The mutant strain and wild-type E1162 were tested on 65 different carbohydrates to identify the substrates of PTS clin , but no significant difference in growth was observed between the 2 strains (data not shown). It is possible that PTS clin is only expressed under the complex conditions that are prevalent in the intestinal tract, which we were unable to replicate in the laboratory.
The
The mutant strain and wild-type E1162 exhibited the same minimum inhibitory concentrations (MICs) for cefoxitin and ceftriaxone, which are 256 and 512 μg/mL, respectively. These 2 strains had the same fitness during competitive growth in BHI and showed an identical growth ratio in BHI supplemented with 20 μg/mL cefoxitin (Supplementary Figure 1) .
To investigate the role of PTS clin in intestinal colonization, cell suspensions of the E1162 strain and its isogenic ptsD-deficient mutant were mixed in a 1:1 ratio (10 7 CFUs of each strain) and used to orogastrically inoculate mice. As shown in Figure 3A and 3B, E. faecium was able to successfully colonize the intestinal tract of mice at high level. The level of colonization in stool samples stabilized at >10 9 CFU/g at all time points. The data presented in Figure 3C showed that the mutant had significant lower viable counts, compared with the wild-type strain, in stool samples collected in all the time points except day 6. Figure 3D demonstrated that the mutant colonized the small intestines and the colon at significantly lower levels than the parental strain. The difference between colonization of the cecum by E1162 and the mutant approached statistical significance (P = .05). We conclude that the deletion of ptsD in E. faecium E1162 resulted in lower intestinal colonization in this mouse model.
DISCUSSION
In this work, we described the identification of a PTS that is enriched in clinical E. faecium isolates and contributes to the intestinal colonization of E. faecium in a mouse model. PTS is crucially important in the uptake and metabolism of carbohydrates in both gram-negative and gram-positive bacteria [26] . Microbes in the intestinal tract interact to form complex food webs for the degradation and metabolism of carbohydrates [27] . Consequently, genes involved in carbohydrate metabolism in gut-dwelling commensals and opportunistic pathogens are of crucial importance for intestinal colonization [27, 28] . In this study, we identified PTS clin as a determinant for intestinal colonization of a clinical E. faecium isolate, indicating the importance of adaptations in carbohydrate metabolism to intestinal colonization of clinical E. faecium strains. Several homologues of PTS clin can be identified in genomes of anaerobic gut commensals. In particular, the IIC and IID subunits have homologs with a high amino acid identity (>65%) in Catenibacterium mitsuokai, Ruminococcus torques, and Ruminococcus gnavus, suggesting that the element in E. faecium may have originated from anaerobes that colonize the mammalian gut. We propose that PTS clin allows E. faecium to benefit from the disturbed metabolic network after the administration of antibiotics. The observation that commensal E. faecium strains do not carry PTS clin indicates that this element does not contribute to colonization of the unperturbed intestinal tract, possibly because of the competition by better adapted, highly abundant, strictly anaerobic gut commensals that carry similar PTS. Another possibility is that the PTS clin could be targeted by certain bacteriocins produced by the gut microflora in healthy humans, since mannose PTSs are common targets of bacteriocins [29] . The data described in this study implicate the significant and previously unrecognized contribution of a PTS in gut colonization of clinical isolates of E. faecium. This is the first description of a genetic determinant that contributes to intestinal colonization in the presence of antibiotics and is specific to clinical isolates of E. faecium.
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